IBT Management Corporation
4
45M
3
0.20
0.25
2
- Areas of investment
Summary
IBT Management Corporation is the famous Corporate Investor, which was founded in 2001. The main department of described Corporate Investor is located in the Taipei. The fund was located in Asia if to be more exact in Taiwan.
The standard case for the fund is to invest in rounds with 9-10 partakers. Despite the IBT Management Corporation, startups are often financed by Sutter Hill Ventures, MPM Capital, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Taiwan Biotech, Prudence Venture Investment Corporation, Industrial Bank of Taiwan. In the next rounds fund is usually obtained by The Baupost Group, Temasek Holdings, Taiwan Biotech.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013. This IBT Management Corporation works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2002.
Among the various public portfolio startups of the fund, we may underline Paratek Pharmaceuticals, Medinox, Medinox For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Biopharma.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.20
- Follow on index
- 0.25
- Investments by industry
- Biopharma (4)
- Biotechnology (3)
- Therapeutics (2)
- Health Care (1)
- Pharmaceutical (1) Show 1 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2007
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 466M
- Group Appearance index
- 1.00
- Avg. company exit year
- 17
- Avg. multiplicator
- 4.12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Portola Pharmaceuticals | 01 Jul 2008 | Biotechnology, Therapeutics, Biopharma | Late Stage Venture | 60M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.